Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice
- 18 February 2010
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 49 (1), 88-94
- https://doi.org/10.1016/j.yjmcc.2010.01.021
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL70079, HL62311, CA084572)
- American Heart Association
This publication has 26 references indexed in Scilit:
- Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injuryBiochemical Journal, 2008
- Improvement of Cardiac Function With Parecoxib, A Cyclo-oxygenase-2 Inhibitor, in a Rat Model of Ischemic Heart FailureJournal of Cardiovascular Pharmacology, 2007
- A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in ratsJournal of Molecular and Cellular Cardiology, 2006
- Transgenic mouse for conditional, tissue‐specific Cox‐2 overexpressionGenesis, 2006
- Thromboxane A2-induced arrhythmias in the anesthetized rabbitAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connectionMolecular Cancer Therapeutics, 2006
- Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditisLife Sciences, 2005
- Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptorAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Prostaglandin F2α Stimulates Hypertrophic Growth of Cultured Neonatal Rat Ventricular MyocytesJournal of Biological Chemistry, 1996
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991